Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22830463 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients
Conditions: Skin Cancer;   Kidney Transplantation
Interventions: Drug: rapamycin;   Drug: ciclosporine;   Drug: tacrolimus

Indicates status has not been verified in more than two years